{"id":70068,"date":"2026-04-13T13:09:04","date_gmt":"2026-04-13T07:39:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=70068"},"modified":"2026-04-13T13:09:07","modified_gmt":"2026-04-13T07:39:07","slug":"why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/","title":{"rendered":"Why Is Divi&#8217;s Laboratories Share Price Falling? Key Reasons &amp; Share Price Target 2026"},"content":{"rendered":"<p>Divi&#8217;s Laboratories share price is down -32% from its 52-week high of Rs 6,200, trading at Rs 4,200 as of April 2026. At its 52-week low of Rs 3,900, the stock has already given up significant gains \u2014 and investors are asking the same question: is this a buying opportunity or a value trap?<\/p><p>The Divi&#8217;s Laboratories share price falling is not random market noise. There are specific, identifiable reasons driving the decline \u2014 and this article examines each of them with real data, sector context, and the analyst consensus on what Divi&#8217;s Laboratories is worth.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free Investment Predictions on Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Why_Is_Divis_Laboratories_Share_Price_Falling_Key_Reasons\" title=\"Why Is Divi&#8217;s Laboratories Share Price Falling? Key Reasons\">Why Is Divi&#8217;s Laboratories Share Price Falling? Key Reasons<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_1_API_Pricing_Pressure_from_Chinese_Competition\" title=\"Reason 1: API Pricing Pressure from Chinese Competition\">Reason 1: API Pricing Pressure from Chinese Competition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_2_CDMO_Business_Ramp_%E2%80%94_Slower_Than_Expected\" title=\"Reason 2: CDMO Business Ramp \u2014 Slower Than Expected\">Reason 2: CDMO Business Ramp \u2014 Slower Than Expected<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_3_Q3_FY26_Earnings_Miss_%E2%80%94_Market_Disappointed\" title=\"Reason 3: Q3 FY26 Earnings Miss \u2014 Market Disappointed\">Reason 3: Q3 FY26 Earnings Miss \u2014 Market Disappointed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_4_High_Valuation_at_52x_PE_for_Slow-Growth_Phase\" title=\"Reason 4: High Valuation at 52x P\/E for Slow-Growth Phase\">Reason 4: High Valuation at 52x P\/E for Slow-Growth Phase<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_5_FDA_Regulatory_Risk\" title=\"Reason 5: FDA Regulatory Risk\">Reason 5: FDA Regulatory Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Divis_Laboratories_Financial_Snapshot\" title=\"Divi&#8217;s Laboratories Financial Snapshot\">Divi&#8217;s Laboratories Financial Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Can_Divis_Laboratories_Recover_Future_Outlook\" title=\"Can Divi&#8217;s Laboratories Recover? Future Outlook\">Can Divi&#8217;s Laboratories Recover? Future Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Divis_Laboratories_Share_Price_Target_2026\" title=\"Divi&#8217;s Laboratories Share Price Target 2026\">Divi&#8217;s Laboratories Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Short-Term_Target_3-6_Months\" title=\"Short-Term Target (3-6 Months)\">Short-Term Target (3-6 Months)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#12-Month_Analyst_Consensus_Target\" title=\"12-Month Analyst Consensus Target\">12-Month Analyst Consensus Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Long-Term_Target_FY28\" title=\"Long-Term Target (FY28)\">Long-Term Target (FY28)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q1_Why_is_Divis_Laboratories_share_price_falling_in_2026\" title=\"Q1. Why is Divi&#8217;s Laboratories share price falling in 2026?\">Q1. Why is Divi&#8217;s Laboratories share price falling in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q2_What_is_Divis_Laboratories_share_price_target_2026\" title=\"Q2. What is Divi&#8217;s Laboratories share price target 2026?\">Q2. What is Divi&#8217;s Laboratories share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q3_Should_I_buy_Divis_Laboratories_at_current_levels\" title=\"Q3. Should I buy Divi&#8217;s Laboratories at current levels?\">Q3. Should I buy Divi&#8217;s Laboratories at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q4_What_is_Divis_Laboratoriess_market_cap_and_PE_ratio\" title=\"Q4. What is Divi&#8217;s Laboratories&#8217;s market cap and P\/E ratio?\">Q4. What is Divi&#8217;s Laboratories&#8217;s market cap and P\/E ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q5_What_can_trigger_recovery_in_Divis_Laboratories_share_price\" title=\"Q5. What can trigger recovery in Divi&#8217;s Laboratories share price?\">Q5. What can trigger recovery in Divi&#8217;s Laboratories share price?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-is-divis-laboratories-share-price-falling-key-reasons-amp-share-price-target-2026\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_Is_Divis_Laboratories_Share_Price_Falling_Key_Reasons\"><\/span><strong>Why Is Divi&#8217;s Laboratories Share Price Falling? Key Reasons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_1_API_Pricing_Pressure_from_Chinese_Competition\"><\/span><strong>Reason 1: API Pricing Pressure from Chinese Competition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Divi&#8217;s Laboratories is one of India&#8217;s largest API (Active Pharmaceutical Ingredient) manufacturers, with strengths in complex APIs and custom synthesis. Chinese API manufacturers have been aggressively pricing generics APIs below sustainable levels \u2014 a pricing war that has compressed Divi&#8217;s realisation per kg across its key API categories. Naproxen, dextromethorphan, and other key APIs have seen 15-20% price erosion over FY25-26.<\/p><p>The US-China trade war should theoretically benefit Indian API manufacturers as US companies seek to de-risk from Chinese supply chains. However, this benefit has been slower to materialise than expected, as qualifying new Indian suppliers for regulated market APIs takes 18-24 months.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_2_CDMO_Business_Ramp_%E2%80%94_Slower_Than_Expected\"><\/span><strong>Reason 2: CDMO Business Ramp \u2014 Slower Than Expected<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Divi&#8217;s Laboratories has been investing in CDMO (Contract Development and Manufacturing Organisation) capacity to serve global innovator pharmaceutical companies with complex synthesis requirements. This segment carries significantly higher margins than generic APIs. The CDMO ramp has been slower than initially projected, with key programmes taking longer to progress through development stages.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_3_Q3_FY26_Earnings_Miss_%E2%80%94_Market_Disappointed\"><\/span><strong>Reason 3: Q3 FY26 Earnings Miss \u2014 Market Disappointed<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Divi&#8217;s Q3 FY26 results came in below expectations on both revenue and PAT. Revenue grew 8% YoY but below the 12-15% expected, and PAT growth of 6% was significantly below the 20% analyst consensus. This earnings miss triggered a sharp sell-off that has continued into Q4 FY26.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_4_High_Valuation_at_52x_PE_for_Slow-Growth_Phase\"><\/span><strong>Reason 4: High Valuation at 52x P\/E for Slow-Growth Phase<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>At 52x trailing P\/E, Divi&#8217;s commands a premium that was justified when earnings were growing at 25-30% annually. With growth slowing to 6-8%, the multiple compression from 65-70x (peak) to 52x is ongoing. Further compression toward 35-40x P\/E on normalised earnings would imply a stock price of Rs 3,500-4,000.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_5_FDA_Regulatory_Risk\"><\/span><strong>Reason 5: FDA Regulatory Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Divi&#8217;s Laboratories has had a clean FDA inspection track record, but the pharmaceutical sector&#8217;s regulatory risk environment is always present. Any Divi&#8217;s facility receiving a warning letter would be a significant negative event given the premium valuation.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Divis_Laboratories_Financial_Snapshot\"><\/span><strong>Divi&#8217;s Laboratories Financial Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td>CMP<\/td><td>Rs 4,200<\/td><\/tr><tr><td>52-Week High<\/td><td>Rs 6,200<\/td><\/tr><tr><td>52-Week Low<\/td><td>Rs 3,900<\/td><\/tr><tr><td>Decline from Peak<\/td><td>-32%<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 1.1L Cr<\/td><\/tr><tr><td>P\/E Ratio<\/td><td>52x<\/td><\/tr><tr><td>P\/B Ratio<\/td><td>7.8x<\/td><\/tr><tr><td>Promoter Holding<\/td><td>51.9%<\/td><\/tr><tr><td>FII Holding<\/td><td>22.6%<\/td><\/tr><tr><td>DII Holding<\/td><td>18.4%<\/td><\/tr><tr><td>Sector<\/td><td>Pharmaceuticals \/ CDMO<\/td><\/tr><\/tbody><\/table><\/figure><p>Track <strong>Divi&#8217;s Laboratories<\/strong> live fundamentals and peer comparisons on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for daily research updates.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Can_Divis_Laboratories_Recover_Future_Outlook\"><\/span><strong>Can Divi&#8217;s Laboratories Recover? Future Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Divi&#8217;s Laboratories&#8217; fundamental capabilities in complex API synthesis and CDMO are among the strongest in India. The current headwinds \u2014 Chinese pricing pressure, slow CDMO ramp \u2014 are real but not permanent. Recovery to Rs 5,000-5,800 requires evidence of CDMO revenue acceleration and API pricing stabilisation. At Rs 4,200 and 52x P\/E, the stock is approaching fair value. Investors with a 2-3 year horizon may find this an attractive entry point.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Divis_Laboratories_Share_Price_Target_2026\"><\/span><strong>Divi&#8217;s Laboratories Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered analyst recommendations<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Short-Term_Target_3-6_Months\"><\/span><strong>Short-Term Target (3-6 Months)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Short-term Divi&#8217;s Laboratories share price target is Rs 3,900-4,500, based on current technical setup and near-term fundamental catalyst timeline. The 52-week low of Rs 3,900 is the key support level \u2014 a sustained break below this would be a significant bearish signal.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12-Month_Analyst_Consensus_Target\"><\/span><strong>12-Month Analyst Consensus Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus 12-month Divi&#8217;s Laboratories share price target is Rs 5,000-5,800, implying meaningful upside from the current Rs 4,200. This assumes the key headwinds identified in this article begin to resolve.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Long-Term_Target_FY28\"><\/span><strong>Long-Term Target (FY28)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In a full recovery scenario, the Divi&#8217;s Laboratories share price target for FY28 is Rs 7,000-8,000. This bull case requires the fundamental concerns in this article to show clear reversal over the next 4-6 quarters.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q1_Why_is_Divis_Laboratories_share_price_falling_in_2026\"><\/span><strong>Q1. Why is Divi&#8217;s Laboratories share price falling in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Divi&#8217;s Laboratories share price is falling primarily due to the reasons detailed in this article. The stock has declined -32% from its 52-week high of Rs 6,200 to the current Rs 4,200. Key factors include sector headwinds, earnings pressure, and broader market conditions. Review all factors before making any investment decision.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q2_What_is_Divis_Laboratories_share_price_target_2026\"><\/span><strong>Q2. What is Divi&#8217;s Laboratories share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus 12-month Divi&#8217;s Laboratories share price target is Rs 5,000-5,800. Short-term target is Rs 3,900-4,500 and long-term FY28 target in a recovery scenario is Rs 7,000-8,000. These are analyst estimates and not guaranteed returns.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q3_Should_I_buy_Divis_Laboratories_at_current_levels\"><\/span><strong>Q3. Should I buy Divi&#8217;s Laboratories at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This article does not provide personalised investment advice. Divi&#8217;s Laboratories is trading at Rs 4,200 with a 52-week range of Rs 3,900 to Rs 6,200. The risk-reward depends on your investment horizon and risk tolerance. Consult a SEBI-registered financial advisor before investing.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q4_What_is_Divis_Laboratoriess_market_cap_and_PE_ratio\"><\/span><strong>Q4. What is Divi&#8217;s Laboratories&#8217;s market cap and P\/E ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Divi&#8217;s Laboratories&#8217;s market capitalisation is Rs 1.1L Cr with a trailing P\/E of 52x and price-to-book ratio of 7.8x. Promoter holding is 51.9%, FII 22.6%, DII 18.4%.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q5_What_can_trigger_recovery_in_Divis_Laboratories_share_price\"><\/span><strong>Q5. What can trigger recovery in Divi&#8217;s Laboratories share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Recovery triggers for Divi&#8217;s Laboratories include: resolution of the specific headwinds identified in this article, positive quarterly results showing reversal of stressed metrics, and broad market recovery. Monitor quarterly results and management commentary closely.<\/p><p><strong>Disclaimer: <\/strong>For educational purposes only. Not investment advice. Consult a SEBI-registered financial advisor. Investments are subject to market risk.<\/p><p>For more analysis, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span>Recent Articles<span class=\"ez-toc-section-end\"><\/span><\/h2><p>&nbsp;<a href=\"https:\/\/univest.in\/blogs\/why-is-krbl-share-price-falling\"><strong>Why is KRBL Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-reliance-infrastructures-share-price-falling\"><strong>Why is Reliance Infrastructures Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-mahanagar-gas-share-price-falling\"><strong>Why is Mahanagar Gas Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-happiest-minds-share-price-falling\"><strong>Why is Happiest Minds Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Divi&#8217;s Laboratories share price is down -32% from its 52-week high of Rs 6,200, trading at Rs 4,200 as of April 2026. At its 52-week low of Rs 3,900, the stock has already given up significant gains \u2014 and investors are asking the same question: is this a buying opportunity or a value trap? The<\/p>\n","protected":false},"author":27,"featured_media":70069,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3818],"class_list":["post-70068","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-falling"],"metadata":{"_edit_lock":["1776065987:27"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["80"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Why Is Divi's Laboratories Share Price Falling? Key Reasons &amp; Share Price Target 2026"],"rank_math_description":["Divi's Laboratories share price falling -32% from 52-week high. Find key reasons, analyst view and Divi's Laboratories share price target for 2026.\n"],"rank_math_focus_keyword":["Divi's Laboratories"],"_thumbnail_id":["70069"],"_edit_last":["27"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["7877"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/13130656\/divi-laboratories.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=70068"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70068\/revisions"}],"predecessor-version":[{"id":70074,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70068\/revisions\/70074"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/70069"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=70068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=70068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=70068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}